Early detection of response to experimental chemotherapeutic Top216 with [18F]FLT and [18F]FDG PET in human ovary cancer xenografts in mice

Mette Munk Jensen, Kamille Dumong Erichsen, Fredrik Björkling, Jacob Madsen, Peter Buhl Jensen, Liselotte Højgaard, Maxwell Sehested, Andreas Kjær

Research output: Contribution to journalJournal articleResearchpeer-review

35 Citations (Scopus)

Abstract

3'-Deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) is a tracer used to assess cell proliferation in vivo. The aim of the study was to use (18)F-FLT positron emission tomography (PET) to study treatment responses to a new anti-cancer compound. To do so, we studied early anti-proliferative effects of the experimental chemotherapy Top216 non-invasively by PET.
Original languageEnglish
JournalP L o S One
Volume5
Issue number9
Pages (from-to)e12965
ISSN1932-6203
DOIs
Publication statusPublished - 1 Jan 2010

Keywords

  • Animals
  • Antineoplastic Agents
  • Cell Proliferation
  • Dideoxynucleosides
  • Disease Models, Animal
  • Drug Monitoring
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Mice
  • Mice, Nude
  • Ovarian Neoplasms
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Xenograft Model Antitumor Assays

Cite this